The Brianna Marie Foundation distributed funds to the following organizations in 2025: American Dental Association (Run for the Kids Race Series) $7832, Brevard Autism Coalition $7613, Cinnacitti Children's Hospital $25K, Fetal Institute $40K
Largest programs · fiscal year 2025
University of Cincinnati Children's Hospital- The Brianna Marie Foundation is proud to partner with Dr. Braxton Forde from Cincinnati Children's Hospital to advance research of synthetic amniotic fluid. When a fetus's kidneys fail, the disorder halts fetal urine production, depriving the lungs of vital amniotic fluid and often leading to fatal respiratory complications at birth. While traditional… Read more
University of Cincinnati Children's Hospital- The Brianna Marie Foundation is proud to partner with Dr. Braxton Forde from Cincinnati Children's Hospital to advance research of synthetic amniotic fluid. When a fetus's kidneys fail, the disorder halts fetal urine production, depriving the lungs of vital amniotic fluid and often leading to fatal respiratory complications at birth. While traditional amnioinfusions using standard IV fluids can improve outcomes, they pose high risks and may even contribute to inflammation. In response, Dr. Forde and his team developed Amnio-well, a synthetic amniotic fluid designed to mimic the natural environment of the womb. Early research has shown it significantly reduces inflammation and promotes healthier lung development. With support from the Brianna Marie Foundation, the team is now conducting advanced studies in pregnant sheep to compare Amnio-well to standard treatments, paving the way for safer, more effective fetal therapies. This work may also benefit other delicate fetal surgeries that rely on amnioinfusions, potentially reducing complications across the board.
Fetal Institute - Miami - 2025 funding from the Brianna Marie Foundation will be crucial in advancing the Fetal Institute's continued research efforts. It will allow them to conduct an animal experiment to validate the technique developed in their previous study and address the technical challenges they encountered. This support will also enable them to evaluate a medical device currently used in… Read more
Fetal Institute - Miami - 2025 funding from the Brianna Marie Foundation will be crucial in advancing the Fetal Institute's continued research efforts. It will allow them to conduct an animal experiment to validate the technique developed in their previous study and address the technical challenges they encountered. This support will also enable them to evaluate a medical device currently used in fetal therapy for a specific condition, expanding its potential applications. Additionally, the funding will help them continue refining an ideal shunting device for managing fetal thoracic fluid collections, including pleural and pericardial effusions, as well as type I CPAM. These contributions will significantly propel our mission to improve outcomes in fetal therapy.
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$80,484Fiscal year 2025
Expenses$82,373Fiscal year 2025
Total assets—Fiscal year 2025
Total liabilities—Fiscal year 2025
Fiscal year ending December2025
Revenue$80,484
Expenses$82,373
Net income−$1,889
Net assets$50,559
Notable sources of revenue
Percent of total revenue
Contributions
$54,713
68.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$25,771
32.0%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$50,559
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$77,655
Expenses$77,119
Net income$536
Net assets$52,348
Notable sources of revenue
Percent of total revenue
Contributions
$40,441
52.1%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$37,214
47.9%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$52,348
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$86,812
Expenses$83,090
Net income$3,722
Net assets$51,812
Notable sources of revenue
Percent of total revenue
Contributions
$51,145
58.9%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$35,667
41.1%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$51,812
Compensation
Not in our extract for this year.
Fiscal year ending December2022
Revenue$32,084
Expenses$63,919
Net income−$31,835
Net assets$48,090
Notable sources of revenue
Percent of total revenue
Contributions
$33,261
103.7%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
−$1,177
−3.7%
Assets / debt
Total assets
$48,090
Total liabilities
$0
Net assets
$48,090
Compensation
Not in our extract for this year.
Fiscal year ending December2021
Revenue$58,176
Expenses$43,059
Net income$15,117
Net assets$76,925
Notable sources of revenue
Percent of total revenue
Contributions
$39,134
67.3%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$19,042
32.7%
Assets / debt
Total assets
$76,925
Total liabilities
$0
Net assets
$76,925
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?